2 Penny Stocks That Could Make You Rich [The Motley Fool]
Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.adaptimmune.com/phoenix.zhtml?c=253991&p=irol-newsarticle&id=2255800
Company Research
Source: The Motley Fool
Penny stocks, defined as equities that trade at less than $ a share, are rarely worth the risk. Companies with extremely low share prices tend to have weak balance sheets, an absurdly high number of outstanding shares, few institutional investors, sky-high levels of interest from short-sellers, and a poor near-term outlook. What's more, these types of equities are often used as day-trading vehicles, making them exceptionally volatile in terms of price.All of that said, there are a select few penny stocks worth buying right now. In fact, these hidden gems may even make their early shareholders rich by the end of the current decade.Which penny stocks stand apart from the crowd?Adaptimmune Therapeutics plc(NASDAQ:ADAPOrganiGram Holdings Inc.NASDAQ:OGIHere's a brief rundown on why these top penny stocks could be big winners for patient investors.Image Source: Getty Images.Adaptimmune: A T-cell focused immuno-oncology companyAdaptimmune's shares have been on fire this year, and for good re
Show less
Read more
Impact Snapshot
Event Time:
ADAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADAP alerts
High impacting Adaptimmune Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ADAP
News
- Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its price target lowered by analysts at Guggenheim from $4.00 to $3.00. They now have a "buy" rating on the stock.MarketBeat
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Adaptimmune Therapeutics plc (NASDAQ: ADAP) had its price target lowered by analysts at HC Wainwright from $4.00 to $3.50. They now have a "buy" rating on the stock.MarketBeat
- Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints [Yahoo! Finance]Yahoo! Finance
ADAP
Earnings
- 11/13/24 - Beat
ADAP
Sec Filings
- 11/13/24 - Form 10-Q
- 11/13/24 - Form 8-K
- 11/13/24 - Form 8-K
- ADAP's page on the SEC website